PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-34.02%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-49.00%
Negative gross profit growth while OBE is at 141.75%. Joel Greenblatt would examine cost competitiveness or demand decline.
-134.64%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-134.64%
Negative operating income growth while OBE is at 102.40%. Joel Greenblatt would press for urgent turnaround measures.
-438.75%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-446.30%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-442.59%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.79%
Share reduction while OBE is at 2.11%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.01%
Reduced diluted shares while OBE is at 0.58%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.79%
Dividend growth at 75-90% of OBE's 0.93%. Bill Ackman would press for a stronger return if the balance sheet allows.
-52.86%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-498.41%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-27.74%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-82.67%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-69.75%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-49.52%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-79.75%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
144.33%
Positive 3Y OCF/share CAGR while OBE is negative. John Neff might see a big short-term edge in operational efficiency.
-198.61%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-588.16%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-129.29%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
-11.04%
Negative equity/share CAGR over 10 years while OBE stands at 36.04%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-75.05%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-73.23%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
760.15%
Stable or rising dividend while OBE is cutting. John Neff sees a strong advantage in consistent shareholder returns vs. a struggling peer.
-48.39%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
-0.10%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
-32.09%
Firm’s AR is declining while OBE shows 19.51%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
-3.39%
Negative asset growth while OBE invests at 1.21%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-10.50%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-0.36%
We’re deleveraging while OBE stands at 10.11%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-66.01%
We cut SG&A while OBE invests at 43.90%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.